MEK and RAF inhibitors for BRAF-mutated cancers
Year: 2012
Type: article
DOI: 10.1017/erm.2012.11
Authors: Sarah Belden, Keith T. Flaherty
Institutions: University of New England, Massachusetts General Hospital
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2161889146